Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer
Clinical trial NCT03358849 · COMPLETED
Trial details
- NCT number
- NCT03358849
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2018-09-27
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.